Intravenous iron therapy for patients with heart failure: expanding body of evidence.
作者信息
Adlbrecht Christopher
机构信息
Department of Cardiology, Vienna North Hospital - Clinic Floridsdorf and the Karl Landsteiner Institute for Cardiovascular and Critical Care Research Vienna, Austria.
出版信息
ESC Heart Fail. 2019 Aug;6(4):581-583. doi: 10.1002/ehf2.12490. Epub 2019 Jul 16.
Abstract
摘要
相似文献
1
Intravenous iron therapy for patients with heart failure: expanding body of evidence.
ESC Heart Fail. 2019 Aug;6(4):581-583. doi: 10.1002/ehf2.12490. Epub 2019 Jul 16.
2
Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome.
Oncologist. 2009;14 Suppl 1:22-33. doi: 10.1634/theoncologist.2009-S1-22.
3
Iron metabolism, anemia, and heart failure.
J Am Coll Cardiol. 2011 Sep 13;58(12):1252-3. doi: 10.1016/j.jacc.2011.03.060.
4
Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France.
ESC Heart Fail. 2019 Jun;6(3):559-569. doi: 10.1002/ehf2.12432. Epub 2019 Apr 25.
5
Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.
J Am Coll Cardiol. 2011 Sep 13;58(12):1241-51. doi: 10.1016/j.jacc.2011.04.040.
6
Retrospective analysis into differences in heart failure patients with and without iron deficiency or anaemia.
ESC Heart Fail. 2019 Aug;6(4):840-855. doi: 10.1002/ehf2.12485. Epub 2019 Jul 9.
7
Structural and functional abnormalities in iron-depleted heart.
Heart Fail Rev. 2019 Mar;24(2):269-277. doi: 10.1007/s10741-018-9738-4.
8
Anemia and iron deficiency in heart failure.
Rev Port Cardiol. 2014 Jan;33(1):39-44. doi: 10.1016/j.repc.2013.06.003. Epub 2013 Nov 9.
9
[Iron and stable ischemic heart disease - lessons from heart failure].
G Ital Cardiol (Rome). 2019 Oct;20(10):559-573. doi: 10.1714/3228.32055.
10
Anemia in heart failure: marker or mediator of adverse prognosis?
J Am Coll Cardiol. 2008 Feb 5;51(5):577-8. doi: 10.1016/j.jacc.2007.09.052.
引用本文的文献
1
Iron replacement therapy in heart failure: a literature review.
Egypt Heart J. 2021 Sep 26;73(1):85. doi: 10.1186/s43044-021-00211-3.
2
Primary care heart failure service identifies a missed cohort of heart failure patients with reduced ejection fraction.
Eur Heart J. 2022 Feb 3;43(5):405-412. doi: 10.1093/eurheartj/ehab629.
3
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting.
Intern Emerg Med. 2021 Jan;16(1):167-170. doi: 10.1007/s11739-020-02434-9. Epub 2020 Jul 10.
本文引用的文献
1
Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR-HF substudy.
ESC Heart Fail. 2019 Aug;6(4):621-628. doi: 10.1002/ehf2.12462. Epub 2019 May 30.
2
The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2019 Feb;21(2):137-155. doi: 10.1002/ejhf.1369. Epub 2019 Jan 1.
3
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11.
4
Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE-HF extended trial.
ESC Heart Fail. 2018 Oct;5(5):788-799. doi: 10.1002/ehf2.12330. Epub 2018 Aug 10.
5
Iron deficiency in chronic heart failure: case-based practical guidance.
ESC Heart Fail. 2018 Oct;5(5):764-771. doi: 10.1002/ehf2.12333. Epub 2018 Aug 2.
6
Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.
Am J Hematol. 2018 May;93(5):683-690. doi: 10.1002/ajh.25060. Epub 2018 Feb 24.
7
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.
Circulation. 2017 Oct 10;136(15):1374-1383. doi: 10.1161/CIRCULATIONAHA.117.027497. Epub 2017 Jul 12.
8
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial.
JAMA. 2017 May 16;317(19):1958-1966. doi: 10.1001/jama.2017.5427.
9
Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
Eur J Heart Fail. 2016 Jul;18(7):786-95. doi: 10.1002/ejhf.473. Epub 2016 Jan 28.
10
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.
Eur J Heart Fail. 2015 Mar;17(3):329-39. doi: 10.1002/ejhf.229. Epub 2015 Feb 11.
Zotero 插件